Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
ENDRA Life Sciences Inc. (NDRA) had Free Cash Flow per Share of $-0.83 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$0.16M |
|
-- |
|
-- |
|
$1.48M |
|
$-1.48M |
|
$1.64M |
|
$0.16M |
|
$0.16M |
|
$0.16M |
|
$0.16M |
|
$0.16M |
|
$0.16M |
|
$-1.48M |
|
$-1.44M |
|
1.32M |
|
2.48M |
|
$0.12 |
|
$0.06 |
|
| Balance Sheet Financials | |
$5.59M |
|
$0.04M |
|
$2.36M |
|
$7.94M |
|
$0.79M |
|
-- |
|
$0.85M |
|
$1.63M |
|
$6.31M |
|
$6.31M |
|
$6.31M |
|
1.50M |
|
| Cash Flow Statement Financials | |
$-2.05M |
|
$2.67M |
|
$4.16M |
|
$0.76M |
|
$5.54M |
|
$4.78M |
|
$1.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
2.53% |
|
2.53% |
|
2.01% |
|
2.53% |
|
$4.21 |
|
|
Free Cash Flow per Share |
$-0.83 |
$-0.83 |
|